knowledge -WSS

knowledge

author：focus 2025-10-01 11:33:31 - browse：4

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： How digital tools helped lower hypertension in marginalized patients

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

What will Novo Nordisk's VC do with its influx of cash?

Will an HIV vaccine ever be a reality?

6 solutions to address cancer drug shortages and others

Congress extends some pandemic preparedness programs

To avoid data mishandling cases, universities eye AI and other tools

focus

knowledge

hotspot

The high cost of giving birth even with insurance

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Malaria cases in Florida and Texas: Here’s what you need to know

Setback for rare diseases as Taysha Gene Therapies pulls back

In age of alternative facts, a scholarly course on calling out crap

WHO recommends second malaria vaccine

Duchenne breakthrough therapy leaves behind pioneering families

KalVista pill reduced swelling 'attacks' caused by genetic disease

23andMe had bad news about my health. I wish a person had delivered it

Why did Pfizer dish out millions for a Super Bowl ad?

knowledge

WHO recommends second malaria vaccine

Study points to new risk in gene therapy death of Terry Horgan

Medicare Advantage proposed rates disappoint insurers

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Medical mystery: When a cough is not just a cough

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

explore

focus

hotspot

focus